Hepion Pharmaceuticals Quote - HEPA

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.1605

Bid

0.1609

Ask

0.167

Volume

3,088,337

0.1602 Day's Range 0.1748

0.121 52 Week Range 3.33

Market Cap

1.117M

Previous Close

0.1707

Open

0.17

Last Trade

360

0.1605

(formt)

Last Trade Time

Financial Volume

US$ 513,049

VWAP

0.166125

Average Volume (3m)

12,144,345

Shares Outstanding

6,958,371

Dividend Yield

PE Ratio

-0.02

Earnings Per Share (EPS)

-7.03

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.17. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.121 to US$ 3.33.

Hepion Pharmaceuticals currently has 6,958,371 shares outstanding. The market capitalization of Hepion Pharmaceuticals is US$1.19 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.02.

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0252	-13.5702746365	0.1857	0.1942	0.1589	7319925	0.18021232	CS
4	-0.0194	-10.7837687604	0.1799	0.28	0.149	30498525	0.20488792	CS
12	-0.4995	-75.6818181818	0.66	0.7345	0.121	12144345	0.20174832	CS
26	-0.5905	-78.6284953395	0.751	0.89	0.121	5353566	0.20383279	CS
52	-2.2595	-93.367768595	2.42	3.33	0.121	2706602	0.22087487	CS
156	-18.0195	-99.1171617162	18.18	26.6	0.121	1064352	2.47374965	CS
260	-90.2395	-99.8224557522	90.4	123.6	0.121	1408394	25.07112959	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is US$ 0.1605

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 1.19M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of US$ 0.121 to US$ 3.33 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.02

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
SXTCChina SXT Pharmaceuticals Inc	US$ 0.84 (145.54%)	29.14M
STECSantech Holdings Limited	US$ 1.575 (142.20%)	122.13M
YYAIConnexa Sports Technologies Inc	US$ 1.245 (94.50%)	152.21M
ATPCAgape ATP Corporation	US$ 1.60 (70.94%)	76.49M
PEPGPepGen Inc	US$ 2.2868 (66.92%)	109.23M
THTarget Hospitality Corporation	US$ 5.10 (-45.51%)	13.06M
ICCTiCoreConnect Inc	US$ 1.33 (-35.12%)	289.74k
STAIScanTech AI Systems Inc	US$ 2.1401 (-34.95%)	5.14M
AGHAureus Greenway Holdings Inc	US$ 3.59 (-33.40%)	987.24k
BOXLBoxlight Corporation	US$ 2.12 (-31.61%)	525.94k
NVDANVIDIA Corporation	US$ 130.28 (-3.09%)	251.18M
PLTRPalantir Technologies Inc	US$ 90.68 (-10.53%)	184.49M
YYAIConnexa Sports Technologies Inc	US$ 1.245 (94.50%)	152.21M
STECSantech Holdings Limited	US$ 1.575 (142.20%)	122.13M
ADTXAditxt Inc	US$ 0.0867 (-5.25%)	119.82M

Symbol

Price

Vol.